Cardiovascular disease is the leading cause of death in women. Decades of grassroots
campaigns have helped to raise awareness about the impact of cardiovascular disease in …

Heart failure (HF) continues to be a major contributor of morbidity and mortality for men and
women alike, yet how the predisposition for, course and management of HF differ between …

Remarkable recent advances have revolutionized the field of heart failure. Survival has
improved among individuals with heart failure and a reduced ejection fraction and for the …

The American Heart Association requests that this document be cited as follows:
Heidenreich PA, Fonarow GC, Breathett K, Jurgens CY, Pisani BA, Pozehl BJ, Spertus JA …

Heart failure affects over 2.6 million women and 3.4 million men in the United States with
known sex differences in epidemiology, management, response to treatment, and outcomes …

This in-depth review of sex differences in advanced heart failure therapy summarizes the
existing literature on implantable cardioverter defibrillators, biventricular pacemakers …

Heart failure (HF) is a leading cause of hospitalisation, morbidity, and mortality in Canada.
There are sex-specific differences in the etiology, epidemiology, comorbidities, treatment …

This Atlas chapter summarizes sex-and some gender-associated, and unique aspects and
manifestations of cardiovascular disease (CVD) in women. CVD is the primary cause of …

Abstract Purpose of Review This review highlights variability in prescribing of
nonpharmacologic heart failure with reduced ejection fraction (HFrEF) therapies by race …

Background: In patients with left bundle branch block (LBBB), QRS duration (QRSd)
depends on left ventricular (LV) dimension. Previously, we demonstrated that normalizing …